retatrutide phase 3 2025 triple agonist glp-1 gip glucagon (Eli Lilly's GLP-1/GIP/Glucagon receptor agonist) just delivered the most impressive obesity + osteoarthritis data we've ever seen in the TRIUMPH-4 trial: Eli Lilly's retatrutide shows promising
Description
PMID: 34049922
Another important factor is the patient's preference
doi: 10.1186/1471-2202-13-33 126 ScottLJ
Semaglutide vs Liraglutide Cost Semaglutide brands (Ozempic, Wegovy) generally cost more than liraglutide (Victoza, Saxenda) due to newer patents and longer-lasting effects
Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus
